The aim of the study was determine activity of chitosan ascorbate against 17 strains of Helicobacter pylori. The strains were isolated from gingival pockets (7 strains) 
Introduction
In 1983, spiral-shaped organisms were isolated from a human gastric biopsy specimen and were named Campylobacter pyloridis [1] [2] [3] . In 1989 Campylobacter pylori was renamed Helicobacter pylori. The Helicobacter pylori (H. pylori) is Gram-negative rods. The bacteria have a spiral shape in young cultures, but can assume coccoid forms in older cultures. The rods are highly motile (3-5 polar flagella) and produces an abundance of urease [2] [3] [4] . These bacteria are catalase-and oxidase-positive, but do not ferment or oxidise carbohydrates [2, 3, 5] . They can metabolize amino acids. The growth of rods is in microaerophilic conditions, with decreased oxygen and increased carbon dioxide [2, 5] . H. pylori rods are protected from phagocytosis and intracellular killing by production the enzymes of catalase and super dismutase. The virulence is connected with vacuolating cytotoxin A that causes damage to host cells. The rods colonized the human gastrointestinal tract in approximately half of all adults and are associated with the development of peptic and duodenal ulcers, chronic gastritis, gastric cancer and has been suggested, with coronary heart disease, cardiovascular risk factors and atherosclerotic vascular disease [6] [7] [8] [9] . Experimental studies have suggested that H. pylori can presence in atherosclerotic plaques to localize in carotid, femoral and iliac artery [10] . The rods has been found in the environmental of the oral cavity i.e. saliva, dental plaque and gingival pockets [11] [12] [13] [14] [15] [16] . The question remains whether oral cavity is permanent reservoir of H. pylori and a potential source of reinfection [11] .
The aim of the study was determine activity of chitosan ascorbate against strains of Helicobacter pylori isolated from various source.
Materials and Methods
A total of 17 strains of Helicobacter pylori isolated from gingival pockets (7 strains), atherosclerotic plaque from carotid (6 strains), femoral (4 strains) and 3 standards strains from following species: Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were examined. Isolates were identified as H. pylori based on morphology, Gram staining and biochemical tests included production of catalase, oxidase and urease (API Campy, bioMerieux). Chitosan ascorbate was obtained from krill chitin and deacetylation degree was equal 60%. The ratio of ascorbic acid to chitosan was equal 1. In the date chitosan was used at the following concentrations: 2.0, 1.0, 0.5, 0.25, 0.12 and 0,06 mg/ml. The susceptibility of the rods was determined by means of the plate dilution technique in Brucella agar supplemented with 5% defibrinated sheep blood. The inoculum containing 10 5 CFU per spot were seeded upon the surface of the medium containing chitosan ascorbate or without chitosan ascorbate (growth control of tested strains). The agar plates were incubated in anaerobic jars with Campy-Pak Plus (BBL) at 37°C for 48 hrs. Minimal inhibitory concentrations (MIC) was interpreted as the lowest concentrations of chitosan ascorbate completely inhibiting the growth of the bacteria.
Results
The data presented in Table 1 show that chitosan ascorbate at the lowest concentrations (MIC in ranges ≤ 0.06 -0.25 mg/ml) was active against 6 (35%) of the strains.
From amongst 17 examined strains of H. pylori, the rods isolated from gingival pockets were the highest susceptible than isolated from atherosclerotic plaques. The chitosan ascorbate inhibited the growth of 4 (57%) strains isolated from gingival pockets at low concentrations from ≤ 0.06 to 0.25 mg/ml. However remaining 3 strains were susceptible to high concentrations of chitosan ascorbate (MIC > 2.0 mg/ml). The strains of H. pylori isolated from carotid plaque were less sensitive. The growth of 2 (33%) of these strains were inhibited by chitosan at concentrations from ≤ 0.06 to 0.12 mg/ml. The growth of remaining 4 strains was inhibited by concentrations > 2.0 mg/ml. The chitosan ascorbate was the least In our previous study [17] Helicobacter pylori strains were isolated from pathological gingival pockets only and they were less susceptible to chitosan ascorbate. Concentrations of chitosan ascorbate in range of ≤ 0.06 -0.5 mg/ml inhibited the growth of 30% those strains obtained from 10 patients with periodontal diseases. In our present data 57% tested strains isolated from gingival pockets was susceptible to concentrations from ≤ 0.06 to 0.25 mg/ml ( Table 1) . The tested standard strains were more resistant to chitosan ascorbate ( 
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Conclusions
The chitosan ascorbate at the lowest concentrations was active against 35% of the all tested strains. The Helicobacter pylori rods isolated from gingival pockets showed the highest susceptible to chitosan ascorbate than strains isolated from atherosclerotic plaques.
